Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy.

Suppr

超能文献

作者信息

Thomas G M

出版信息

N Engl J Med. 1999 Apr 15;340(15):1198-200. doi: 10.1056/NEJM199904153401509.

DOI:10.1056/NEJM199904153401509

PMID:10202172

Abstract

摘要

相似文献

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy.

N Engl J Med. 1999 Apr 15;340(15):1198-200. doi: 10.1056/NEJM199904153401509.

Treatment of high-risk cervical cancer.

N Engl J Med. 1999 Aug 26;341(9):695-6; author reply 696-7. doi: 10.1056/NEJM199908263410913.

Treatment of high-risk cervical cancer.

N Engl J Med. 1999 Aug 26;341(9):696-7.

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

N Engl J Med. 1999 Apr 15;340(15):1137-43. doi: 10.1056/NEJM199904153401501.

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

N Engl J Med. 1999 Apr 15;340(15):1144-53. doi: 10.1056/NEJM199904153401502.

Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.

Strahlenther Onkol. 2001 Dec;177(12):635-40.

Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.

Strahlenther Onkol. 2005 Aug;181(8):545-50. doi: 10.1007/s00066-005-1340-8.

[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].

Ai Zheng. 2008 Sep;27(9):942-6.

[Radiotherapy concomitant with cisplatin chemotherapy in the treatment of cancer of the cervix uteri].

Rev Med Chir Soc Med Nat Iasi. 1995 Jan-Jun;99(1-2):99-102.

[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].

Bull Cancer. 1999 Oct;86(10):829-41.

引用本文的文献

Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.

Ther Adv Med Oncol. 2025 Oct 3;17:17588359251379397. doi: 10.1177/17588359251379397. eCollection 2025.

Survival outcomes in IIIC cervical cancer by treatment strategies: a systematic review and meta-analysis.

BMC Cancer. 2025 Aug 20;25(1):1340. doi: 10.1186/s12885-025-14697-6.

Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer.

JAMA Netw Open. 2025 Mar 3;8(3):e250033. doi: 10.1001/jamanetworkopen.2025.0033.

Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer.

Probiotics Antimicrob Proteins. 2025 Feb 14. doi: 10.1007/s12602-025-10479-5.

Artificial Intelligence Algorithms in Predictive Factors for Hematologic Toxicities During Concurrent Chemoradiation for Cervical Cancer.

Cureus. 2024 Oct 1;16(10):e70665. doi: 10.7759/cureus.70665. eCollection 2024 Oct.

Cisplatin-Containing Combinations Associate with Survival in Women from Appalachian Kentucky with Metastatic, Persistent, or Recurrent Uterine Cervix Cancer.

Cancers (Basel). 2024 Sep 28;16(19):3319. doi: 10.3390/cancers16193319.

Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.

Cancer Immunol Immunother. 2024 Oct 3;73(12):244. doi: 10.1007/s00262-024-03823-1.

Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer.

Front Nucl Med. 2023 May 17;3:1138552. doi: 10.3389/fnume.2023.1138552. eCollection 2023.

Implementation of Brachytherapy for Patients With Cervical Cancer in Ethiopia: A 3-Year Practice Report.

JCO Glob Oncol. 2023 Aug;9:e2200407. doi: 10.1200/GO.22.00407.

Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

J Contemp Brachytherapy. 2023 Feb;15(1):27-36. doi: 10.5114/jcb.2023.124936. Epub 2023 Feb 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验